Clinical relevance immunohistochemical detection multidrug resistance P-glycoprotein breast carcinoma women breast carcinoma advanced cancer metastases expression P-glycoprotein start chemotherapy regimen resistance-related drugs use monoclonal antibody avidin-biotin-immunoperoxidase technique P-glycoprotein tumor samples Results semiquantitative manner account number positive tumor cells index specific intensity index patients nonmetastatic cancer first cycle chemotherapy cancer recurrence subsequent cycles chemotherapy patients disease-free surgery and/or radiation end point local/regional recurrence metastasis Strong P-glycoprotein-positive staining majority tumor cells N+/I+ phenotype initial response progression-free survival pretreatment evaluation P-glycoprotein expression prognostic value patients advanced breast cancer 